Publisher Correction: The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M.

Sci Rep

Institute of Biomedical Sciences, National Chung Hsing University, No. 145, Xingda Rd., South Dist., Taichung, 402, Taiwan.

Published: August 2021

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405629	PMC
http://dx.doi.org/10.1038/s41598-021-97248-w	DOI Listing

Publication Analysis

publisher correction

correction impact

impact first-line

first-line egfr-tkis

egfr-tkis clinical

clinical outcome

outcome sequential

sequential osimertinib

osimertinib treatment

treatment advanced

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!